Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 ,inter alia, to consider and approve Unaudited Financial Results for ....
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma has informed BSE and NSE that its Board of Directors will meet on Friday, 06th February 2026 at the registered office. The key agenda is to consider and approve the Unaudited Financial Results for the quarter ended 31st December 2025 (Q3 FY26). The filing also notes the trading window for designated persons and their immediate relatives is closed from 01st January 2026 and will remain closed until 48 hours after results are declared, reopening on 08th February 2026. The intimation is made under SEBI Listing Regulations (Regulation 29). No financial figures are disclosed in this filing.
This is a routine regulatory intimation and does not itself move the stock. Investors should watch for the actual Q3 FY26 results on 06th February 2026, as the numbers released that day could drive short-term price action.